Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
So Much for Trump Going After Pharma
Source: Bloomberg
So Much for Trump Going After Pharma
By Max Nisen
June 20, 2017 12:21 PM EDT
President Donald Trump has gone from promising to bring down drug prices to looking like he's been captured by Big Pharma in just a few short months.
The president started out the year ripping into drugmakers and threatening to make firms bid for government business. Now? Rather than pushing for pricing legislation, his administration is reportedly settling for an executive order -- which, according to a Kaiser Health News report, may end up looking more like a pharma wish list than a menu of onerous demands.
The regulations the industry fears most include those that would give the government more negotiating power and limit drug monopolies. Those increasingly seem to be off the table. Even a strong executive order has limitations, and Trump's apparently will not be strong.
Drug stocks have been on the rise this year. Evidence of softer treatment from the White House may give them more momentum.
[font size=1]-snip-[/font]
By Max Nisen
June 20, 2017 12:21 PM EDT
President Donald Trump has gone from promising to bring down drug prices to looking like he's been captured by Big Pharma in just a few short months.
The president started out the year ripping into drugmakers and threatening to make firms bid for government business. Now? Rather than pushing for pricing legislation, his administration is reportedly settling for an executive order -- which, according to a Kaiser Health News report, may end up looking more like a pharma wish list than a menu of onerous demands.
The regulations the industry fears most include those that would give the government more negotiating power and limit drug monopolies. Those increasingly seem to be off the table. Even a strong executive order has limitations, and Trump's apparently will not be strong.
Drug stocks have been on the rise this year. Evidence of softer treatment from the White House may give them more momentum.
[font size=1]-snip-[/font]
Read more: https://www.bloomberg.com/gadfly/articles/2017-06-20/trump-drug-price-promise-seems-likely-to-be-broken
1 replies
= new reply since forum marked as read
= new reply since forum marked as read
